Oramed Pharmaceuticals Inc (ORMP)
2.40
+0.02
(+0.84%)
USD |
NASDAQ |
May 10, 16:00
2.40
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Enterprise Value: -15.53M for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 09, 2024 | -15.53M |
| May 08, 2024 | -13.50M |
| May 07, 2024 | -14.72M |
| May 06, 2024 | -11.07M |
| May 03, 2024 | -16.74M |
| May 02, 2024 | -17.15M |
| May 01, 2024 | -17.15M |
| April 30, 2024 | -17.96M |
| April 29, 2024 | -13.30M |
| April 26, 2024 | -12.28M |
| April 25, 2024 | -18.77M |
| April 24, 2024 | -15.93M |
| April 23, 2024 | -16.74M |
| April 22, 2024 | -17.55M |
| April 19, 2024 | -19.98M |
| April 18, 2024 | -22.82M |
| April 17, 2024 | -17.55M |
| April 16, 2024 | -14.72M |
| April 15, 2024 | -13.91M |
| April 12, 2024 | -9.854M |
| April 11, 2024 | -7.422M |
| April 10, 2024 | -4.181M |
| April 09, 2024 | -2.965M |
| April 08, 2024 | 0.2762M |
| April 05, 2024 | -6.207M |
| Date | Value |
|---|---|
| April 04, 2024 | -6.207M |
| April 03, 2024 | -0.5342M |
| April 02, 2024 | 1.492M |
| April 01, 2024 | 2.707M |
| March 28, 2024 | 6.354M |
| March 27, 2024 | 2.302M |
| March 26, 2024 | -1.750M |
| March 25, 2024 | -0.129M |
| March 22, 2024 | 5.949M |
| March 21, 2024 | 1.492M |
| March 20, 2024 | 7.975M |
| March 19, 2024 | 2.707M |
| March 18, 2024 | 1.897M |
| March 15, 2024 | 6.354M |
| March 14, 2024 | -3.370M |
| March 13, 2024 | 0.2762M |
| March 12, 2024 | 3.923M |
| March 11, 2024 | 7.164M |
| March 08, 2024 | 8.785M |
| March 07, 2024 | 3.923M |
| March 06, 2024 | 4.328M |
| March 05, 2024 | 19.54M |
| March 04, 2024 | 19.14M |
| March 01, 2024 | 26.00M |
| February 29, 2024 | 20.75M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-80.02M
Minimum
Jan 26 2023
1.038B
Maximum
Nov 08 2021
121.58M
Average
44.85M
Median
Apr 09 2020
Enterprise Value Benchmarks
| Inogen Inc | 74.24M |
| Petros Pharmaceuticals Inc | -0.5067M |
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.645M |
| Palatin Technologies Inc | 28.44M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 13.34M |
| Total Expenses (Quarterly) | 3.877M |
| EPS Diluted (Quarterly) | 0.33 |
| Earnings Yield | 5.83% |
| Normalized Earnings Yield | -21.25 |